why choose us

First received: October 31, 2023

Clinical Trial: A Phase 2 Study to Assess the Efficacy and Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Neovascular Age-Related Macular Degeneration (nAMD)

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Multicenter, Randomized, Double-Masked, Parallel Group Study to Assess the Efficacy and Safety of KHK4951, a Vascular Endothelial Growth Factor Receptor Inhibitor, in Patients With Neovascu

Brief Summary: The purpose of this study is to evaluate efficacy and safety of KHK4951 eye drops in patients with nAMD.

Read more